Skip to content
synovial sarcoma foundation
  • About
    • Mission
    • Initiatives
    • Affiliations
    • Leadership
    • Board of Directors
    • Careers
  • Resources
    • Synovial Sarcoma FAQ
    • Treatments
    • Clinical Trials & Therapies
    • Synovial Sarcoma Patient Survey
    • Synovial Sarcoma Tumor Board
    • Patient Stories
  • Research Programs
    • Clinical Research
    • Tumor Glow
    • Synovial Sarcoma Registry
  • Latest News
Donate

Send us a note

Please fill out the form below and we will gladly respond as soon as possible.

Edit Content

    Latest News, Synovial Sarcoma Registry

    Celebrating Milestones with Hope: The 100th Sign-Up for the Synovial Sarcoma Registry and Biospecimen Repository

    December 23, 2025 ayushis Comments Off on Celebrating Milestones with Hope: The 100th Sign-Up for the Synovial Sarcoma Registry and Biospecimen Repository
    A woman with short brown hair smiles at the camera outdoors. She is wearing a black sweater and a dark top, with light makeup and a natural background behind her.

    We are thrilled to announce a significant milestone for the Synovial Sarcoma Registry and Biospecimen Repository, as we proudly welcome our 100th registrant. This achievement signifies the growing commitment to advancing research and improving treatment options for patients with synovial sarcoma.

    The registry serves as a pivotal resource, collecting invaluable data and biospecimens from patients diagnosed with synovial sarcoma. By participating, patients contribute to a collective effort to understand this rare form of cancer better and develop innovative treatment plans that can lead to improved outcomes. Every registration helps researchers in their mission to tailor therapies more effectively, offering hope to individuals and families affected by this challenging condition.

    Meet Carrie Carpunky: Our 100th Registrant

    Among the many courageous individuals contributing to this critical endeavor is Carrie Carpunky, our milestone registrant. Carrie’s journey with cancer began in 2010, when she experienced persistent stomach pains attributed initially to stress and a possible ulcer. It wasn’t until she consulted a gastrointestinal specialist that the word “tumor” entered her reality, launching her into a whirlwind of tests, emotions, and eventually, a cancer diagnosis.

    A collage of five photos featuring a woman with brown hair, sometimes with a man or a younger woman, in various settings including outdoors, smiling selfies, and with a yellow “10 Years Free” shirt and red mask.

    Carrie’s story is one of resilience. After a partial gastrectomy procedure, she found herself grappling with the ramifications of her diagnosis. Yet through the ups and downs of her journey—including a tumor that remained localized against the odds and the anguish of watching her symptoms evolve—she found an incredible ally in her oncologist, Dr. Brian VanTine, who provided care and compassion throughout her experience.

    Following years of diligent monitoring and treatment, Carrie has reached a point where she goes for annual check-ups, underscoring the value of early intervention and unwavering support. The recent loss of Dr. VanTine deeply affected her. “He was more than my oncologist; he was a friend,” Carrie reflects, highlighting the bond that forms between patients and their healthcare providers.

    Get Involved

    We invite anyone diagnosed with synovial sarcoma to join the Synovial Sarcoma Registry and contribute to this crucial research effort. By participating, you are not only helping us build a comprehensive resource for researchers but also becoming part of a community that believes in the potential for better treatments and outcomes.

    To learn more about registering and participating in this vital initiative, please visit our official page: Synovial Sarcoma Registry.

    As we celebrate this milestone with Carrie and all our registrants, we renew our commitment to gathering insights that could drive breakthroughs in understanding synovial sarcoma. Together, we can make significant strides towards better therapies and, ultimately, a brighter future for those affected by this disease.

    Read Carrie’s journey here, and explore more stories from other patients by visiting our Patient Stories section. Each story offers a powerful reminder of the resilience within this community and the impact of collective participation in advancing research.

    ayushis

    Post navigation

    Previous
    Next

    Search

    Categories

    • Black Flag Racing (2)
    • CHOP (3)
    • Development (2)
    • Dr. Theodore Laetsch (3)
    • Education (2)
    • Healthcare (2)
    • Latest News (6)
    • Research (11)
    • Synovial Sarcoma Conference (2)
    • Synovial Sarcoma Registry (3)
    • Teresa Belluco (1)
    • Tumor Board (2)

    Recent posts

    • A gloved hand holds a clear petri dish near a microscope in a bright laboratory setting, suggesting scientific research or experiment.
      UI Health Care Begins Treating Patients With TCR Therapy for Synovial Sarcoma
    • Close-up of a gloved hand adjusting the focus knobs on a laboratory microscope, with lens details visible and a specimen slide illuminated on the stage.
      Prasterone (DHEA) for Metastatic or Unresectable Synovial Sarcoma
    • A woman with short brown hair smiles at the camera outdoors. She is wearing a black sweater and a dark top, with light makeup and a natural background behind her.
      Celebrating Milestones with Hope: The 100th Sign-Up for the Synovial Sarcoma Registry and Biospecimen Repository

    Tags

    Black Flag Racing Brigham and Women’s Hospital Callan Spence cancer-testis antigen Cancer Research Chase Spence Chas Spence CHOP Community Engagement & Partnerships Manager Conference Cure Dr. Rachel Hurly Dr. Ted Laetsch Dr. Theodore W. Laetsch fibroblast fibroblast epigenome grant ground breaking human cell therapy immune-cell therapy JAMA Internal Medicine Julie Kramer MAGE-A4 Nathan Imperiale National Tumor Board Nature Communications Patient Stories Pediatric Oncology Penn Medicine Synovial Sarcoma Foundation Prasterone Rare Cancer rare disease research Sarcoma SUMO2 inhibitors Synovial Sarcoma Synovial Sarcoma Foundation synovial sarcoma survivor synovial sarcoma treatment TAK-981 TCR-NK TCR Therapy TECELRA Zelluna ZI-MA4-1

    Related posts

    A gloved hand holds a clear petri dish near a microscope in a bright laboratory setting, suggesting scientific research or experiment.
    Healthcare, Latest News, Research

    UI Health Care Begins Treating Patients With TCR Therapy for Synovial Sarcoma

    January 21, 2026 ayushis Comments Off on UI Health Care Begins Treating Patients With TCR Therapy for Synovial Sarcoma

    UI Health Care has begun treating eligible patients with synovial sarcoma using a new form of immunotherapy known as T cell receptor (TCR) therapy. This treatment approach represents an important step forward in expanding access to innovative options for people facing advanced synovial sarcoma. A targeted immune-based approach TCR therapy is designed to help the […]

    Close-up of a gloved hand adjusting the focus knobs on a laboratory microscope, with lens details visible and a specimen slide illuminated on the stage.
    Latest News, Research

    Prasterone (DHEA) for Metastatic or Unresectable Synovial Sarcoma

    January 12, 2026 ayushis Comments Off on Prasterone (DHEA) for Metastatic or Unresectable Synovial Sarcoma

    Researchers have studied prasterone—also known as DHEA (dehydroepiandrosterone)—as a potential treatment option for people with synovial sarcoma that has spread (metastatic) or cannot be removed through surgery. This clinical study was designed to better understand the safety of prasterone, determine appropriate dosing, and explore whether it could help slow or control disease progression. This trial […]

    Large and small translucent bubbles float over a marbled blue, gray, and black background, creating an abstract, fluid pattern.
    Research

    A New Cell Therapy Approach Advances Toward Clinical Testing in Synovial Sarcoma

    December 22, 2025 joshs Comments Off on A New Cell Therapy Approach Advances Toward Clinical Testing in Synovial Sarcoma

    Zelluna, a Norway-based biotechnology company, has announced the submission of a Clinical Trial Application (CTA) in the United Kingdom for ZI-MA4-1 (ZIMA-101), a first-in-human cell therapy study that will include patients with synovial sarcoma. While this trial is still in its earliest phase, it represents a notable scientific development for the synovial sarcoma community. What […]

    The Synovial Sarcoma Foundation is a registered 501(c)(3) nonprofit organization. Tax ID number is 33-4027591. Contributions to the Synovial Sarcoma Foundation are tax-deductible to the extent permitted by law.

    • Terms & conditions
    • Privacy policy
    synovial sarcoma foundation
    • community@synovialsarcoma.org
    Facebook-f X-twitter Linkedin

    Navigation

    • About
    • Research Programs
    • Patient Stories
    • Resources

    Stay in touch